184 related articles for article (PubMed ID: 11764181)
1. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases.
Lindenbaum Y; Dickson D; Rosenbaum P; Kraemer K; Robbins I; Rapin I
Eur J Paediatr Neurol; 2001; 5(6):225-42. PubMed ID: 11764181
[TBL] [Abstract][Full Text] [Related]
2. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
3. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
4. Cockayne syndrome in adults: review with clinical and pathologic study of a new case.
Rapin I; Weidenheim K; Lindenbaum Y; Rosenbaum P; Merchant SN; Krishna S; Dickson DW
J Child Neurol; 2006 Nov; 21(11):991-1006. PubMed ID: 17092472
[TBL] [Abstract][Full Text] [Related]
5. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
6. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy.
Zafeiriou DI; Thorel F; Andreou A; Kleijer WJ; Raams A; Garritsen VH; Gombakis N; Jaspers NG; Clarkson SG
Pediatr Res; 2001 Mar; 49(3):407-12. PubMed ID: 11228268
[TBL] [Abstract][Full Text] [Related]
9. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
10. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
Ito S; Kuraoka I; Chymkowitch P; Compe E; Takedachi A; Ishigami C; Coin F; Egly JM; Tanaka K
Mol Cell; 2007 Apr; 26(2):231-43. PubMed ID: 17466625
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Transcription Elongation by the XPG-TFIIH Complex Is Implicated in Cockayne Syndrome.
Narita T; Narita K; Takedachi A; Saijo M; Tanaka K
Mol Cell Biol; 2015 Sep; 35(18):3178-88. PubMed ID: 26149386
[TBL] [Abstract][Full Text] [Related]
12. [Function of XPG gene and symptoms caused by its defect].
Shiomi T
Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):902-7. PubMed ID: 11436315
[No Abstract] [Full Text] [Related]
13. Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit.
Hijazi H; Salih MA; Hamad MH; Hassan HH; Salih SB; Mohamed KA; Mukhtar MM; Karrar ZA; Ansari S; Ibrahim N; Alkuraya FS
Clin Genet; 2015; 87(1):56-61. PubMed ID: 24354460
[TBL] [Abstract][Full Text] [Related]
14. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.
Le Page F; Kwoh EE; Avrutskaya A; Gentil A; Leadon SA; Sarasin A; Cooper PK
Cell; 2000 Apr; 101(2):159-71. PubMed ID: 10786832
[TBL] [Abstract][Full Text] [Related]
15. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
16. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
[TBL] [Abstract][Full Text] [Related]
17. Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes.
Murai M; Enokido Y; Inamura N; Yoshino M; Nakatsu Y; van der Horst GT; Hoeijmakers JH; Tanaka K; Hatanaka H
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13379-84. PubMed ID: 11687625
[TBL] [Abstract][Full Text] [Related]
18. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
[TBL] [Abstract][Full Text] [Related]
19. Brain vascular changes in Cockayne syndrome.
Hayashi M; Miwa-Saito N; Tanuma N; Kubota M
Neuropathology; 2012 Apr; 32(2):113-7. PubMed ID: 21749465
[TBL] [Abstract][Full Text] [Related]
20. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.
Tsutakawa SE; Sarker AH; Ng C; Arvai AS; Shin DS; Shih B; Jiang S; Thwin AC; Tsai MS; Willcox A; Her MZ; Trego KS; Raetz AG; Rosenberg D; Bacolla A; Hammel M; Griffith JD; Cooper PK; Tainer JA
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14127-14138. PubMed ID: 32522879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
